A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
Recruiting · NCT07299825 · Registry updated 2026-05-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer | Her 2 Positive Breast Cancer | Recruiting | Phase 2 | 2026-05-08 | NCT07299825 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 52 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henan Provincial Cancer Hospital | Zhenzhou | China | 1 |